|
Showing 1 - 2 of
2 matches in All Departments
Fungal pathogens pose an on-going and serious threat for
poikilotherms and homeotherms, and can cause a broad spectrum of
diseases ranging from innocuous to life-threatening. In addition,
long-term exposure to some mycotoxigenic moulds can lead to
mycotoxicoses in human and animals. Given the expanding population
of immune compromised hosts, the list of fungal opportunists grows
longer every year. Moreover, antifungal resistance, drug-related
toxicity and our limited arsenal of antifungals have exacerbated
the situation. To address these problems, strategies such as the
identification of novel targets, use of the structure-activity
relationship in rational drug design, development of new
formulations, modification of existing antifungals to combat
resistance, and bioavailability enhancement are called for. For the
reader's convenience, this book has been divided into three
sections. The first six chapters of Section I provide a timely
review of mycoses, from endemic to cosmopolitan and from
generalized to specific, while both chapters of Section II focus on
risks associated with mycotoxins. In closing, the two chapters of
Section III describe potential antifungal leads and drug candidates
based on phytochemicals and coumarin scaffold.
Fungal pathogens pose an on-going and serious threat for
poikilotherms and homeotherms, and can cause a broad spectrum of
diseases ranging from innocuous to life-threatening. In addition,
long-term exposure to some mycotoxigenic moulds can lead to
mycotoxicoses in human and animals. Given the expanding population
of immune compromised hosts, the list of fungal opportunists grows
longer every year. Moreover, antifungal resistance, drug-related
toxicity and our limited arsenal of antifungals have exacerbated
the situation. To address these problems, strategies such as the
identification of novel targets, use of the structure-activity
relationship in rational drug design, development of new
formulations, modification of existing antifungals to combat
resistance, and bioavailability enhancement are called for. For the
reader's convenience, this book has been divided into three
sections. The first six chapters of Section I provide a timely
review of mycoses, from endemic to cosmopolitan and from
generalized to specific, while both chapters of Section II focus on
risks associated with mycotoxins. In closing, the two chapters of
Section III describe potential antifungal leads and drug candidates
based on phytochemicals and coumarin scaffold.
|
You may like...
Al Wat Tel
Irma Venter
Paperback
R330
R229
Discovery Miles 2 290
Simply Lies
David Baldacci
Paperback
R340
R266
Discovery Miles 2 660
1979
Val McDermid
Paperback
R484
R400
Discovery Miles 4 000
Zero Hour
Don Bentley
Paperback
R488
R404
Discovery Miles 4 040
Good Hope
Nick Clelland
Paperback
R350
R255
Discovery Miles 2 550
In At The Kill
Gerald Seymour
Paperback
R483
R398
Discovery Miles 3 980
|